Integrated API and finished-dosage generics maker expanding into new markets
MSN Laboratories is a Hyderabad-based pharmaceutical manufacturer making active pharmaceutical ingredients and finished dosages, with in-house R&D covering both. Hiring is accelerating and heavily sales-led, spread across India, Australia, Brazil, Guatemala and Colombia, which points to an international commercial push. Job posts center on launch readiness, product registrations and hospital tenders. The stack pairs SAP with Power BI and IQVIA, alongside lab tooling such as HPLC, UPLC and LC-MS.
MSN Laboratories is a privately held, research-based pharmaceutical group headquartered in Hyderabad, Telangana, founded in 2003. It develops and manufactures both active pharmaceutical ingredients and finished dosage forms, operating facilities in India and the USA. Its specialties include APIs, finished dosages, branded generics, R&D and CDMS. The portfolio spans therapeutic areas such as oncology, cardiology, CNS, diabetes and nephrology, with products reaching patients in many countries. The company employs more than 10,000 people.
MSN Laboratories uses SAP, Power BI, Power Query, Looker Studio, IQVIA, Zoho, Tally and QuickBooks. Its lab tooling includes HPLC, UPLC, LC-MS and SDS-PAGE, and its creative work runs on Adobe tools.
MSN Laboratories is hiring in India, Australia, Brazil, Guatemala and Colombia. Hiring is accelerating and weighted toward sales, with additional roles in product, data, legal, logistics, quality and research.
MSN Laboratories is headquartered in Hyderabad, Telangana State, India. It operates API and finished-dosage manufacturing facilities in India and the USA.
Other companies in the same industry, closest in size
MSN Laboratories's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.